High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$181K
$181,408
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2026-02-23
$67,669
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2026-02-23 | $67,669 | S | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2026-02-18
$16,635
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2026-02-18 | $16,635 | S | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2025-11-24
$58,256
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2025-11-24 | $58,256 | S | Form 4 |
|
KALV
M
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Other
2025-11-20
$376
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Other
|
2025-11-20 | $376 | M | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2025-11-18
$38,848
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2025-11-18 | $38,848 | S | Form 4 |